Yes, ArcaScience Platform is easily integrated into internal pharma IT standards since 2023
Our fastest implementations range from minutes for SaaS access to about one week for a Private Cloud setup. One product, one indication, public and/or internal data, plus one reviewer: output delivered within a week, with no automatic roll-over into a larger program.
EEA-based and self-hosted, with zero retention and no training on your data. The pilot uses public data only, so nothing of yours ever moves.
Publications aside, ask us for a Blind Approval. We give you access to the platform, or one of its outputs, and deliver a single, fully worked benefit-risk evaluation on your molecule and target, so you can measure us against your internal standards.
The ArcaScience BRA Platform was reviewed by the FDA in 2025 and qualified on both its technology and its outputs. Beyond that, we operationalize the frameworks regulators already use: the platform delivers decision support and submission-ready deliverables. You remain the MAH and the accountable party, while benefiting from the platform's credibility and efficiency.
Our business model is milestone-based: you either win, or you lose nothing. We even encourage clients to work the same problem in parallel if they wish: it makes benchmarking easy and demonstrates the ArcaScience Platform's value more clearly. You should own the capability; let us own the delivery.
Do you have more questions ?
Contact us
If you have any questions, require assistance, or need to schedule an appointment, we encourage you to contact us.